• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于控制阿尔茨海默病个体及相关病理特征的化学工具开发的结构与机制洞察

Structural and Mechanistic Insights into Development of Chemical Tools to Control Individual and Inter-Related Pathological Features in Alzheimer's Disease.

作者信息

Lee Hyuck Jin, Korshavn Kyle J, Nam Younwoo, Kang Juhye, Paul Thomas J, Kerr Richard A, Youn Il Seung, Ozbil Mehmet, Kim Kwang S, Ruotolo Brandon T, Prabhakar Rajeev, Ramamoorthy Ayyalusamy, Lim Mi Hee

机构信息

School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, Republic of Korea.

Department of Chemistry, University of Michigan, Ann Arbor, Michigan, 48109, USA.

出版信息

Chemistry. 2017 Feb 21;23(11):2706-2715. doi: 10.1002/chem.201605401. Epub 2017 Jan 26.

DOI:10.1002/chem.201605401
PMID:28004889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5826595/
Abstract

To elucidate the involvement of individual and inter-related pathological factors [i.e., amyloid-β (Aβ), metals, and oxidative stress] in the pathogenesis of Alzheimer's disease (AD), chemical tools have been developed. Characteristics required for such tool construction, however, have not been clearly identified; thus, the optimization of available tools or new design has been limited. Here, key structural properties and mechanisms that can determine tools' regulatory reactivities with multiple pathogenic features found in AD are reported. A series of small molecules was built up through rational structural selection and variations onto the framework of a tool useful for in vitro and in vivo metal-Aβ investigation. Variations include: (i) location and number of an Aβ interacting moiety; (ii) metal binding site; and (iii) denticity and structural flexibility. Detailed biochemical, biophysical, and computational studies were able to provide a foundation of how to originate molecular formulas to devise chemical tools capable of controlling the reactivities of various pathological components through distinct mechanisms. Overall, this multidisciplinary investigation illustrates a structure-mechanism-based strategy of tool invention for such a complicated brain disease.

摘要

为了阐明个体及相互关联的病理因素[即β淀粉样蛋白(Aβ)、金属和氧化应激]在阿尔茨海默病(AD)发病机制中的作用,人们开发了化学工具。然而,构建此类工具所需的特性尚未明确界定;因此,现有工具的优化或新设计受到了限制。本文报道了能够决定工具对AD中多种致病特征的调节反应性的关键结构特性和机制。通过对用于体外和体内金属-Aβ研究的工具框架进行合理的结构选择和变化,构建了一系列小分子。变化包括:(i)Aβ相互作用部分的位置和数量;(ii)金属结合位点;(iii)配位数和结构灵活性。详细的生化、生物物理和计算研究能够为如何推导分子式以设计能够通过不同机制控制各种病理成分反应性的化学工具提供基础。总体而言,这项多学科研究阐明了针对这种复杂脑部疾病基于结构-机制的工具发明策略。

相似文献

1
Structural and Mechanistic Insights into Development of Chemical Tools to Control Individual and Inter-Related Pathological Features in Alzheimer's Disease.用于控制阿尔茨海默病个体及相关病理特征的化学工具开发的结构与机制洞察
Chemistry. 2017 Feb 21;23(11):2706-2715. doi: 10.1002/chem.201605401. Epub 2017 Jan 26.
2
The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.正在寻找小分子以研究阿尔茨海默病中与金属相关的淀粉样-β 物种。
Acc Chem Res. 2014 Aug 19;47(8):2475-82. doi: 10.1021/ar500152x. Epub 2014 Jul 31.
3
Minor Structural Variations of Small Molecules Tune Regulatory Activities toward Pathological Factors in Alzheimer's Disease.小分子的微小结构变异调节对阿尔茨海默病病理因素的调控活性。
ChemMedChem. 2017 Nov 22;12(22):1828-1838. doi: 10.1002/cmdc.201700456. Epub 2017 Oct 9.
4
Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.深入了解化学工具设计的机制,以控制阿尔茨海默病中的多种致病特征。
Acc Chem Res. 2021 Oct 19;54(20):3930-3940. doi: 10.1021/acs.accounts.1c00457. Epub 2021 Oct 4.
5
Tuning Structures and Properties for Developing Novel Chemical Tools toward Distinct Pathogenic Elements in Alzheimer's Disease.针对阿尔茨海默病中不同的致病因素,调整结构和性质,开发新型化学工具。
ACS Chem Neurosci. 2018 Apr 18;9(4):800-808. doi: 10.1021/acschemneuro.7b00454. Epub 2017 Dec 28.
6
Importance of the Dimethylamino Functionality on a Multifunctional Framework for Regulating Metals, Amyloid-β, and Oxidative Stress in Alzheimer's Disease.二甲基氨基官能团在用于调节阿尔茨海默病中的金属、β-淀粉样蛋白和氧化应激的多功能框架中的重要性。
Inorg Chem. 2016 May 16;55(10):5000-13. doi: 10.1021/acs.inorgchem.6b00525. Epub 2016 Apr 27.
7
Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer's disease.基于结构-机制的阿尔茨海默病中不同病理因素靶向化学调节剂的工程设计。
Nat Commun. 2016 Oct 13;7:13115. doi: 10.1038/ncomms13115.
8
Strategic Design of 2,2'-Bipyridine Derivatives to Modulate Metal-Amyloid-β Aggregation.用于调节金属-淀粉样蛋白-β聚集的2,2'-联吡啶衍生物的战略设计
Inorg Chem. 2017 Jun 5;56(11):6695-6705. doi: 10.1021/acs.inorgchem.7b00782. Epub 2017 May 9.
9
Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.多巴胺及其衍生物对阿尔茨海默病中非金属诱导和金属诱导的β淀粉样蛋白聚集、氧化应激和炎症的调节作用。
ACS Chem Neurosci. 2018 Nov 21;9(11):2655-2666. doi: 10.1021/acschemneuro.8b00122. Epub 2018 Jun 8.
10
Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-β species.用于靶向和调节金属-淀粉样β物种的二芳基乙烯衍生物的开发。
Inorg Chem. 2011 Nov 7;50(21):10724-34. doi: 10.1021/ic2012205. Epub 2011 Sep 28.

引用本文的文献

1
Rationally Designed Pentapeptide Analogs of Aβ19-23 Fragment as Potent Inhibitors of Aβ42 Aggregation.理性设计的Aβ19-23片段五肽类似物作为Aβ42聚集的强效抑制剂
Molecules. 2025 May 7;30(9):2071. doi: 10.3390/molecules30092071.
2
Leveraging heterocycle-fused 1,4-benzoquinone to design chemical modulators for both metal-free and metal-bound amyloid-β.利用杂环稠合的1,4-苯醌设计无金属和金属结合淀粉样β蛋白的化学调节剂。
Chem Sci. 2025 Mar 12;16(16):6930-6942. doi: 10.1039/d4sc06070a. eCollection 2025 Apr 16.
3
Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.

本文引用的文献

1
Chelation-induced diradical formation as an approach to modulation of the amyloid-β aggregation pathway.螯合诱导双自由基形成作为调节淀粉样β蛋白聚集途径的一种方法。
Chem Sci. 2015 Feb 1;6(2):1018-1026. doi: 10.1039/c4sc01979b. Epub 2014 Oct 30.
2
A rationally designed small molecule for identifying an link between metal-amyloid-β complexes and the pathogenesis of Alzheimer's disease.一种用于确定金属-淀粉样β蛋白复合物与阿尔茨海默病发病机制之间联系的合理设计的小分子。
Chem Sci. 2015 Mar 1;6(3):1879-1886. doi: 10.1039/c4sc03239j. Epub 2015 Jan 27.
3
Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer's disease.
氧化还原活性金属离子与阿尔茨海默病中的淀粉样肽降解酶。
Int J Mol Sci. 2021 Jul 19;22(14):7697. doi: 10.3390/ijms22147697.
4
The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation.镍螯合剂丁二酮肟可抑制人淀粉样β肽的体外聚集。
Sci Rep. 2021 Mar 23;11(1):6622. doi: 10.1038/s41598-021-86060-1.
5
Rationally designed peptide-based inhibitor of Aβ42 fibril formation and toxicity: a potential therapeutic strategy for Alzheimer's disease.理性设计的 Aβ42 纤维形成和毒性的肽类抑制剂:阿尔茨海默病的潜在治疗策略。
Biochem J. 2020 Jun 12;477(11):2039-2054. doi: 10.1042/BCJ20200290.
6
Mechanistic approaches for chemically modifying the coordination sphere of copper-amyloid-β complexes.用于化学修饰铜-淀粉样β复合物配位球的机理方法。
Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5160-5167. doi: 10.1073/pnas.1916944117. Epub 2020 Feb 26.
7
Tailoring Hydrophobic Interactions between Probes and Amyloid-β Peptides for Fluorescent Monitoring of Amyloid-β Aggregation.定制探针与淀粉样β肽之间的疏水相互作用以进行淀粉样β聚集的荧光监测。
ACS Omega. 2018 May 11;3(5):5141-5154. doi: 10.1021/acsomega.8b00286. eCollection 2018 May 31.
8
Minor Structural Variations of Small Molecules Tune Regulatory Activities toward Pathological Factors in Alzheimer's Disease.小分子的微小结构变异调节对阿尔茨海默病病理因素的调控活性。
ChemMedChem. 2017 Nov 22;12(22):1828-1838. doi: 10.1002/cmdc.201700456. Epub 2017 Oct 9.
基于结构-机制的阿尔茨海默病中不同病理因素靶向化学调节剂的工程设计。
Nat Commun. 2016 Oct 13;7:13115. doi: 10.1038/ncomms13115.
4
Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease.阿尔茨海默病淀粉样蛋白假说的十大挑战。
J Alzheimers Dis. 2017;55(2):447-457. doi: 10.3233/JAD-160550.
5
Importance of the Dimethylamino Functionality on a Multifunctional Framework for Regulating Metals, Amyloid-β, and Oxidative Stress in Alzheimer's Disease.二甲基氨基官能团在用于调节阿尔茨海默病中的金属、β-淀粉样蛋白和氧化应激的多功能框架中的重要性。
Inorg Chem. 2016 May 16;55(10):5000-13. doi: 10.1021/acs.inorgchem.6b00525. Epub 2016 Apr 27.
6
A Redox-Active, Compact Molecule for Cross-Linking Amyloidogenic Peptides into Nontoxic, Off-Pathway Aggregates: In Vitro and In Vivo Efficacy and Molecular Mechanisms.一种用于将淀粉样生成肽交联成无毒、非途径聚集体的氧化还原活性紧凑分子:体外和体内疗效及分子机制
J Am Chem Soc. 2015 Nov 25;137(46):14785-97. doi: 10.1021/jacs.5b10043. Epub 2015 Nov 17.
7
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.阿尔茨海默病和帕金森病中的铁神经化学:治疗靶点
J Neurochem. 2016 Oct;139 Suppl 1:179-197. doi: 10.1111/jnc.13425. Epub 2016 Feb 10.
8
Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease.设计一种具有潜在用途的结构框架,用于开发靶向和调节阿尔茨海默病多个方面的化学试剂。
J Am Chem Soc. 2014 Jan 8;136(1):299-310. doi: 10.1021/ja409801p. Epub 2013 Dec 27.
9
A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease.一种对与阿尔茨海默病相关的铜 - 淀粉样β蛋白和锌 - 淀粉样β蛋白表现出显著反应性的小分子。
Chem Commun (Camb). 2014 May 25;50(40):5301-3. doi: 10.1039/c3cc48473d. Epub 2013 Dec 10.
10
Copper and heme-mediated Abeta toxicity: redox chemistry, Abeta oxidations and anti-ROS compounds.铜和血红素介导的 Abeta 毒性:氧化还原化学、Abeta 氧化和抗 ROS 化合物。
Curr Top Med Chem. 2012;12(22):2573-95. doi: 10.2174/1568026611212220011.